Supply Chain

Johnson & Johnson subsidiary McNeil-PPC reached a $33 million settlement with 43 states to resolve allegations the company sold contaminated drugs and used inappropriate marketing practices, reports Pittsburgh Post-Gazette.

Waltham, Mass.-based Bioverativ will purchase True North Therapeutics, a San Francisco-based biotech, for $400 million, reports Boston Globe.

The Food and Drug Administration on Tuesday approved a new use for Merck's best-selling cancer drug, Keytruda, based on a patient's individual genetic makeup, rather than the physical location of the tumor, reports Reuters.

Newly-merged healthcare organizations can generate significant revenue through various pharmacy-related solutions, according to Alex Minkoff, senior director of health systems strategy at AmerisourceBergen.

Some of the most expensive medications on the market treat a rare disease or cancer, and often represent the first approved treatment for the condition, according to a study from Waltham, Mass.–based life science consulting firm Trinity Partners.

An intriguing discrepancy stood out in our recent survey of 400 hospital stakeholders.

The Food and Drug Administration on Monday expanded the approved use of Roche's arthritis drug, Actemra.

Cook Medical on May 16 received clearance from the Food and Drug Administration for its Flourish Pediatric Esophageal Atresia device.

The healthcare technology company Philips will purchase St. Paul, Minn.-based RespirTech for an undisclosed amount, reports StarTrbune.

The Food and Drug Administration on Monday approved Sanofi and Regeneron Pharmaceutical's biologic drug Kevzara.